Medical Properties Trust Valuation
Is M2PW34 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of M2PW34 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: M2PW34 (R$11.52) wird unter unserer Schätzung des Fair Value (R$19.35) gehandelt.
Deutlich unter dem Marktwert: M2PW34 wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for M2PW34?
Other financial metrics that can be useful for relative valuation.
What is M2PW34's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$2.43b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 13.9x |
Enterprise Value/EBITDA | 28.9x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does M2PW34's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 10.4x | ||
BTLG11 BTG Pactual Logística Fundo de Investimento Imobiliário | 15.4x | n/a | R$3.1b |
KNRI11 Kinea Renda Imobiliária Fundo de Investimento Imobiliário | 11.5x | n/a | R$3.9b |
NHI National Health Investors | 8.2x | 11.2% | US$2.6b |
COFB Cofinimmo | 6.5x | 2.4% | €2.3b |
M2PW34 Medical Properties Trust | 2.7x | 4.7% | R$2.4b |
Price-To-Sales gegen Gleichaltrige: M2PW34 ist ein guter Wert, wenn man sein Price-To-Sales Verhältnis (1.6x) mit dem Durchschnitt der anderen Unternehmen (9.8x) vergleicht.
Price to Earnings Ratio vs Industry
How does M2PW34's PE Ratio compare vs other companies in the Global Health Care REITs Industry?
Price-To-Sales gegen Industrie: M2PW34 ist aufgrund seines Price-To-Sales Verhältnisses (1.6x) im Vergleich zum Global Health Care REITs Branchendurchschnitt (6.7x) ein guter Wert.
Price to Sales Ratio vs Fair Ratio
What is M2PW34's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 2.7x |
Fair PS Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von M2PW34 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.